Journal article
Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia
Abstract
BACKGROUND: Serum biomarkers may identify people at risk for cardiovascular (CV) outcomes. Biobanked serum samples from 8494 participants with dysglycemia in the completed Outcome Reduction With Initial Glargine Intervention trial were assayed for 284 biomarkers to identify those that could identify people at risk for a CV outcome or death when added to clinical measurements.
METHODS AND RESULTS: A multiplex analysis measured a panel of …
Authors
Gerstein HC; Paré G; McQueen MJ; Haenel H; Lee SF; Pogue J; Maggioni AP; Yusuf S; Hess S
Journal
Circulation, Vol. 132, No. 24, pp. 2297–2304
Publisher
Wolters Kluwer
Publication Date
December 15, 2015
DOI
10.1161/circulationaha.115.015744
ISSN
0009-7322